Ligand Pharmaceuticals Inc. (NASDAQ:LGND) CEO Sells $3712500.00 in Stock

Sunday, 11 Feb, 2018

Corecommodity Management Llc bought 35,862 shares as the company's stock declined 17.45% while stock markets rallied. The hedge fund run by Andy Redleaf held 5.33M shares of the oil & gas production company at the end of 2017Q3, valued at $110.94M, down from 6.77 million at the end of the previous reported quarter. The stock increased 0.21% or $0.03 during the last trading session, reaching $14.48. About 391,870 shares traded or 47.90% up from the average.

Ligand Pharmaceuticals (NASDAQ:LGND) had its price target lifted by analysts at HC Wainwright from $159.00 to $170.00 in a note issued to investors on Wednesday, January 24th, MarketBeat reports. It has underperformed by 26.01% the S&P500.

Eagle Boston Investment Management Inc increased its stake in Cross Country Healthcare Inc (CCRN) by 3.74% based on its latest 2017Q3 regulatory filing with the SEC. The institutional investor held 71,413 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $9.72 million, up from 67,669 at the end of the previous reported quarter. Whitebox Advisors Llc who had been investing in Par Pacific Holdings Inc for a number of months, seems to be less bullish one the $773.20M market cap company. The stock increased 1.48% or $0.19 during the last trading session, reaching $13. It increased, as 19 investors sold Ligand Pharmaceuticals Incorporated shares while 68 reduced holdings. (NASDAQ:CCRN) has declined 8.78% since February 10, 2017 and is downtrending. It has outperformed by 74.38% the S&P500. Finally, Deutsche Bank lowered shares of Ligand Pharmaceuticals from a "hold" rating to a "sell" rating and set a $105.00 target price on the a report on Monday, November 20th. Therefore 50% are positive. Ligand Pharmaceuticals had 24 analyst reports since September 3, 2015 according to SRatingsIntel. The stock has "Buy" rating by Roth Capital on Friday, December 18. The firm has "Buy" rating given on Tuesday, September 5 by H.C. Wainwright. BMO Capital Markets maintained it with "Buy" rating and $1500 target in Tuesday, July 11 report. On Monday, January 8 the stock rating was maintained by SunTrust with "Buy". The stock has "Buy" rating by TH Capital on Friday, December 18. The stock of Autodesk, Inc. The firm has "Buy" rating by Canaccord Genuity given on Wednesday, August 2. The firm has "Sell" rating by Deutsche Bank given on Monday, November 20. The firm earned "Hold" rating on Wednesday, October 18 by KeyBanc Capital Markets.

Investors sentiment increased to 2.02 in 2017 Q3. Its up 0.45, from 1.24 in 2017Q2.

In other Ligand Pharmaceuticals news, Director Stephen L. Sabba sold 925 shares of the company's stock in a transaction dated Wednesday, December 20th. Swiss Natl Bank stated it has 34,900 shares or 0.01% of all its holdings. The company has market cap of $3.17 billion. (NASDAQ:ADSK) for 2,000 shares. First Light Asset Mngmt Ltd invested in 2.73% or 63,346 shares. Advsr Asset Management Inc reported 0.01% of its portfolio in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND). The Connecticut-based Matarin Cap Limited Liability Corp has invested 0.31% in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND). Meridian Inv Counsel Inc reported 3,170 shares stake. (NASDAQ:ADSK) for 350,432 shares. Jpmorgan Chase And has invested 0.01% in Autodesk, Inc. Stifel Financial holds 0.05% in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) or 109,124 shares. Parametric Portfolio Associate Llc accumulated 202,029 shares. (NASDAQ:ADSK) on Monday, August 28. Vanguard Group Inc. now owns 1,741,818 shares of the biotechnology company's stock valued at $211,457,000 after acquiring an additional 54,200 shares during the period.

Analysts await Teleflex Incorporated (NYSE:TFX) to report earnings on February, 22. As Kyprolis approaches blockbuster status, considering certain factors we think should be able to easily push it over the edge, and they include: 1) recent FDA approval of sNDA based on ENDEAVOR overall survival data; 2) recent CHMP positive opinion to include updated overall survival from ENDEAVOR on label this year in the European Union; and 3) recent submission of sNDA to FDA and a variation to the marketing authorization to the EMA, both based on the overall survival benefit from the ASPIRE study (actions expected this year). LGND's profit would be $19.42 million giving it 40.78 P/E if the $0.92 EPS is correct. After $2.12 actual earnings per share reported by Teleflex Incorporated for the previous quarter, Wall Street now forecasts 12.26% EPS growth. It also reduced its holding in Green Dot Corp (NYSE:GDOT) by 22,474 shares in the quarter, leaving it with 114,083 shares, and cut its stake in Supernus Pharmaceuticals Inc C (NASDAQ:SUPN). Two investment analysts have rated the stock with a sell rating, one has given a hold rating, four have given a buy rating and one has issued a strong buy rating to the stock. Therefore 32% are positive. Cross Country Healthcare had 16 analyst reports since August 9, 2015 according to SRatingsIntel. The firm has "Buy" rating by Roth Capital given on Friday, March 11. Brean Capital maintained Teleflex Incorporated (NYSE:TFX) on Friday, February 26 with "Buy" rating. The rating was maintained by TH Capital on Thursday, November 19 with "Buy". The stock presently has a consensus rating of Buy and a consensus price target of $150.83. Jefferies maintained PPL Corporation (NYSE:PPL) on Tuesday, June 20 with "Hold" rating. The stock of General Electric Company (NYSE:GE) has "Outperform" rating given on Monday, November 23 by Credit Suisse. D E Shaw And invested in 36,832 shares. 49 funds opened positions while 102 raised stakes. Conestoga Advsr Limited holds 433,125 shares or 2.61% of its portfolio. Thrivent For Lutherans reported 12,840 shares. Pacad Investment Limited has 300 shares for 0.01% of their portfolio. Invesco owns 122,403 shares. Craig Hallum maintained Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) on Wednesday, November 15 with "Buy" rating. Bnp Paribas Arbitrage Sa owns 10,844 shares for 0% of their portfolio. Gideon Capital Advsrs stated it has 3,114 shares. M&T Bancorporation Corporation invested 0.01% in Teleflex Incorporated (NYSE:TFX).

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing and acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Barton Management, a Pennsylvania-based fund reported 1,200 shares. Wedge Mngmt L Ltd Partnership Nc accumulated 29,453 shares.

Since August 23, 2017, it had 0 insider purchases, and 6 selling transactions for $9.43 million activity.